KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Depreciation and Depletion (2016 - 2025)

Evolent Health (EVH) has 11 years of Depreciation and Depletion data on record, last reported at $6.3 million in Q4 2025.

  • For Q4 2025, Depreciation and Depletion fell 14.86% year-over-year to $6.3 million; the TTM value through Dec 2025 reached $26.3 million, down 13.2%, while the annual FY2025 figure was $26.3 million, 13.2% down from the prior year.
  • Depreciation and Depletion reached $6.3 million in Q4 2025 per EVH's latest filing, down from $6.4 million in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $8.9 million in Q4 2022 and bottomed at $6.3 million in Q2 2025.
  • Average Depreciation and Depletion over 5 years is $7.6 million, with a median of $7.6 million recorded in 2021.
  • Peak YoY movement for Depreciation and Depletion: increased 14.71% in 2021, then fell 20.25% in 2025.
  • A 5-year view of Depreciation and Depletion shows it stood at $7.8 million in 2021, then grew by 14.1% to $8.9 million in 2022, then dropped by 14.61% to $7.6 million in 2023, then dropped by 2.63% to $7.4 million in 2024, then decreased by 14.86% to $6.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation and Depletion were $6.3 million in Q4 2025, $6.4 million in Q3 2025, and $6.3 million in Q2 2025.